Abstract
Perianal complications occur in approximately 33% of patients with Crohn's disease, and may be the most prominent or even the presenting complaint suggestive of a diagnosis of Crohn's disease. A case is reported of severe perianal Crohn's disease with anal destruction and incontinence that developed after perianal surgery. Healing of perianal lesions and recovery of anal function was achieved with infliximab therapy.
Similar content being viewed by others
References
Pescatori M, Interisano A, Basso L, et al. Management of perianal Crohn's disease: results of a multicenter study in Italy. Dis Colon Rectum 1995 Feb; 38: 121–4
Nordgren S, Fasth S, Hultén L. Anal fistulas in Crohn's disease: incidence and outcome of surgical treatment. Int J Colorectal Dis 1992 Dec; 7(4): 214–18
Jeffery PJ, Parks AG, Ritchie JK. Treatment of haemorroids in patients with inflammatory bowel disease. Lancet 1977 May 21; 1(8021): 1084–5
Morrison JG, Gathright Jr JB, Ray JE, et al. Surgical management of anorectal fistulas in Crohn's disease. Dis Colon Rectum 1989 Jun; 32(6): 492–6
Allan A, Keighley MR. Management of perianal Crohn disease. World J Surg 1988 Apr; 12: 198–202
Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999 May 6; 340(18): 1398–405
Acknowledgments
Dr Caetano received honoraria for the submission of the case report, which was funded by Schering-Plough/MSD Portugal. Editorial assistance was provided by Ray Hill, of in Science Communications, a Wolters Kluwer business. This assistance was funded by Schering-Plough/MSD Portugal.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caetano, C. Infliximab Aids Recovery of Anal Continence in a Patient with Perianal Crohn's Disease. BioDrugs 24 (Suppl 1), 22–24 (2010). https://doi.org/10.2165/11586270-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11586270-000000000-00000